Astrana Health, Inc. Stock Price, News & Analysis

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported strong financial results for the year ended December 31, 2020, exceeding all guidance metrics. Total revenue reached $687.2 million, a 23% increase from the previous year, with a net income of $122.3 million, a significant rise from $17.7 million in 2019. The fourth quarter saw revenue of $176.8 million, slightly down from $178.8 million in Q4 2019, but net income turned positive at $12.9 million, compared to a loss in the same period last year. ApolloMed has also established a strategic alliance with CAIPA MSO, expanding its presence in New York.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced the appointment of Dr. Jeremy R. Jackson as Chief of Staff, effective March 10, 2021. Dr. Jackson brings 10 years of healthcare experience, previously serving at Boston Consulting Group and Brigham and Women's Hospital. His role will involve collaborating with the executive team on technology, business development, and strategy projects. Executive Chairman Kenneth Sim emphasized Dr. Jackson's healthcare insights as pivotal for ApolloMed's growth strategy, while Dr. Jackson expressed enthusiasm for improving patient outcomes through integrated value-based care management.

Apollo Medical Holdings (NASDAQ: AMEH) announced that its management team, including Dr. Kenneth Sim and Eric Chin, will present at the Barclays Global Healthcare Conference on March 11, 2021. The presentation is scheduled for 7:20 a.m. PT / 10:20 a.m. ET and will be available via live webcast. Following the event, a recording will be accessible on ApolloMed's website. The company focuses on physician-centric, technology-powered healthcare management, aiming to enhance patient care while managing costs effectively.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has announced its financial results for Q4 and the year ended December 31, 2020, will be released after the market closes on March 10, 2021. A conference call will follow at 2 p.m. PT / 5 p.m. ET to discuss the results. ApolloMed is a physician-centric, technology-powered healthcare management company focused on delivering quality care through risk-bearing models and a proprietary healthcare platform. This earnings release is anticipated by investors for insights into the company's performance.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced that its subsidiary, APA ACO, generated $37.3 million in gross savings for the 2019 performance year, leading to $19.8 million in shared savings from CMS. APA ACO operates under the Next Generation ACO Model and achieved actual expenditures of $467.6 million against a benchmark of $504.9 million. The company's CEO highlighted this success as a testament to their physician-centric care model, supported by proprietary technologies. They continue to focus on enhancing their population health management platform.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has appointed Brandon Sim as Chief Operating Officer (COO), effective February 3, 2021. Previously serving as Chief Technology Officer, Sim will now oversee the company's strategy and non-clinical operations while continuing to lead its technology initiatives. Thomas S. Lam, Co-CEO, emphasized that this promotion will enhance ApolloMed's operational excellence and innovation in healthcare management. Founded in 2019, Sim has significantly improved operational efficiencies and patient outcomes, aiming to scale ApolloMed's population health management model nationwide.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has announced a strategic alliance with CAIPA MSO, LLC, investing to acquire a 30% interest in CAIPA MSO. This partnership aims to enhance healthcare management services in New York, leveraging ApolloMed's population health management technology with CAIPA MSO's network of over 1,000 providers. Serving around 500,000 patients, CAIPA is recognized for its quality care. The investment marks ApolloMed's entry into the New York market and aligns with its national expansion strategy, expected to close within six months.

Apollo Medical Holdings (NASDAQ: AMEH) has formed a strategic alliance with CAIPA MSO, investing to acquire 30% of CAIPA MSO's membership interests. This partnership aims to combine ApolloMed's healthcare management technology with CAIPA's expertise in New York's healthcare market, enhancing service delivery to over 1.6 million patients. The transaction is expected to close within three to six months, pending customary consents. ApolloMed's entry into New York aligns with its nationwide expansion plan, focusing on improving quality and cost-effectiveness of patient care.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced its participation in the Credit Suisse 29th Virtual Annual Healthcare Conference on November 12, 2020, at 3:30 p.m. ET. Key executives, including Kenneth Sim, M.D., will present and participate in one-on-one virtual meetings. The presentation will be accessible via live webcast, with a recording available later on the company's website. ApolloMed focuses on a physician-centric, technology-enabled healthcare management model aimed at enhancing care quality while reducing costs.